Dong Lin, Cao Yejin, Hou Yueru, Liu Guangwei
Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education, Department of Biology, College of Life Sciences, Beijing Normal University, Beijing, China.
J Cell Physiol. 2022 Jan;237(1):329-345. doi: 10.1002/jcp.30576. Epub 2021 Sep 13.
N -methyladenosine (m A) RNA methylation is a reversible posttranscriptional modification in eukaryotes involving three types of functional proteins: "writers", "erasers", and "readers". m A regulates the metabolism of messenger RNAs and noncoding RNAs through RNA structure, splicing, stability, export, and translation, thereby participating in various physiological and pathological processes. Here, we summarize the current state of m A methylation researches, focusing on how these modifications modulate the fate decisions of innate and adaptive immune cells and regulate immune responses in immune-associated diseases, including viral infections and cancer. These studies showed that m A modifications and m A modifying proteins play a critical role in pathogen recognition, immune cell activation, immune cell fate decisions, and immune reactions. m A is a novel regulator of immune system homeostasis and activation.
N6-甲基腺苷(m6A)RNA甲基化是真核生物中一种可逆的转录后修饰,涉及三种功能蛋白:“书写者”“擦除者”和“阅读者”。m6A通过RNA结构、剪接、稳定性、输出和翻译来调节信使RNA和非编码RNA的代谢,从而参与各种生理和病理过程。在此,我们总结了m6A甲基化研究的现状,重点关注这些修饰如何调节先天性和适应性免疫细胞的命运决定,并在包括病毒感染和癌症在内的免疫相关疾病中调节免疫反应。这些研究表明,m6A修饰和m6A修饰蛋白在病原体识别、免疫细胞激活、免疫细胞命运决定和免疫反应中起关键作用。m6A是免疫系统稳态和激活的新型调节因子。